Computed Tomography Angiography to Brain Death Assessment
|ClinicalTrials.gov Identifier: NCT02045407|
Recruitment Status : Completed
First Posted : January 24, 2014
Last Update Posted : January 10, 2017
|Condition or disease|
Critically ill patients, presenting Glasgow Coma Score 5 or lower, will be submitted to the Computed Tomography Angiography (CTA) of the skull assessment, and follow a clinical evaluation for brain death, additionally, transcranial Doppler would be applied as the gold standard for brain death.
We will exclude patients whose do not can be submitted to contrast injection, or if a brain death clinical evaluation has been performed prior the CTA.
|Study Type :||Observational|
|Actual Enrollment :||91 participants|
|Observational Model:||Case Control|
|Official Title:||Computed Tomography Angiography to Brain Death Assessment|
|Study Start Date :||January 2014|
|Actual Primary Completion Date :||December 2016|
|Actual Study Completion Date :||December 2016|
- Assess the presence or absence of contrast medium filling of the intracranial vessels in comatose patients. [ Time Frame: 1 year ]After excluding confounding factors, we will submit comatose patients to CTA. Immediately after the exam, we will perform clinical evaluation for brain death and calculate CTA sensibility and specificity for this diagnosis. Time between these two interventions will be measured.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02045407
|Hospital das Clínicas da Faculdade de Medicina da USP.|
|São Paulo, Brazil, 05403000|
|Principal Investigator:||Sergio Brasil, MD||University of Sao Paulo|